These study findings show that weight loss occurred early among patients with advanced gastric cancer and was associated with shorter overall survival.
Investigators suggest more personalized interventions may be needed to improve adherence rates among women with breast cancer receiving AI treatments.
Multiple genes predispose African-American women to breast cancer.
This study also showed a gradual increase in cognitive impairment at 12 months that persisted at 24 and 36 months for patients receiving endocrine therapy alone.
Nearly half of cancer research has been stopped due to the COVID-19 pandemic.
Women participating in mammography screening have a significant reduction in the risk for dying of breast cancer and in the rate of advanced breast cancers.
Exact risk-adapted starting ages for CRC could be used to better counsel individuals about the appropriate age to be screened.
In guidance issued by the COVID-19 Pandemic Breast Cancer Consortium, recommendations are presented for prioritizing care for breast cancer patients during the COVID-19 pandemic.
The investigators sought to describe HRQOL and treatment satisfaction of ibrutinib-treated patients with CLL in the real-world setting.
High total fiber consumption is associated with a reduced risk for breast cancer.
Expanded testing could increase detection of carriers for BRCA1/2, mutations in other predisposition genes.
Fecal immunochemical tests have proven to be an effective, noninvasive approach to detect later-stage colorectal cancer; however, questions remain regarding their ability to consistently identify early-stage cancers.
12.5 percent of those meeting USPSTF recommendations for low-dose CT had screening exam in past year.
No significant reductions found in 8-year breast cancer mortality for continuing vs stopping screening.
Medical and ethical considerations of fertility preservation in children with cancer are addressed in a clinical report from the American Academy of Pediatrics.
Odds of reporting cancer diagnosis increased for those with 10 or more lifetime sexual partners
The ROW risk calculator makes its predictions based on age, comorbidities, functional status, tumor characteristics, and use of radiotherapy.
J Clin Med Res. 2019;11(4):247-255.
Quality of life in patients receiving netupitant/palonosetron chemotherapy induced nausea and vomiting.
Many breast cancer drugs approved in the United States may lack substantial clinical benefit, particularly in the palliative setting.